Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
24 July 2023Website:
http://www.aeonbiopharma.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 22:28:48 GMTDividend
Analysts recommendations
Institutional Ownership
AEON Latest News
AEON Biopharma, Inc. (AEON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Recently experiencing a decrease in value, AEON Biopharma, Inc. (AEON) has now shown a hammer chart pattern, suggesting that the stock has found a level of support. This, along with an increase in earnings estimate revisions, may result in a potential turnaround for the stock in the near future.
Atalaya Capital Management LP (Trades, Portfolio), a New York-based investment firm, recently made a significant acquisition in AEON Biopharma Inc. This article will delve into the details of the transaction, provide an overview of both Atalaya Capital Management LP (Trades, Portfolio) and AEON Biopharma Inc, and analyze the potential impact of this acquisition on the firm's portfolio and the traded company's stock performance.
What type of business is AEON Biopharma?
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
What sector is AEON Biopharma in?
AEON Biopharma is in the Healthcare sector
What industry is AEON Biopharma in?
AEON Biopharma is in the Biotechnology industry
What country is AEON Biopharma from?
AEON Biopharma is headquartered in United States
When did AEON Biopharma go public?
AEON Biopharma initial public offering (IPO) was on 24 July 2023
What is AEON Biopharma website?
http://www.aeonbiopharma.com
Is AEON Biopharma in the S&P 500?
No, AEON Biopharma is not included in the S&P 500 index
Is AEON Biopharma in the NASDAQ 100?
No, AEON Biopharma is not included in the NASDAQ 100 index
Is AEON Biopharma in the Dow Jones?
No, AEON Biopharma is not included in the Dow Jones index
When does AEON Biopharma report earnings?
The next expected earnings date for AEON Biopharma is 30 August 2024